Valcon Medical A/S: Financial statements 2023
CVR: 40086714
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Valcon Medical A/S (CVR 40086714) has filed annual accounts for 2023. In 2023, the company reported a gross profit of EUR -15,119,165 and a net result of EUR -30,261,603 compared with DKK -17,079,193 the year before. Equity in the 2023 report amounted to EUR 38,684,019. The solvency ratio was 76.9%. The company had 19 employees in the financial year.
- Gross Profit
- EUR -15,119,165
- Profit/Loss
- EUR -30,261,603
- Equity
- EUR 38,684,019
- Total Assets
- EUR 50,293,963
- Employees
- 19
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -15.1M EUR | -30.3M EUR | 38.7M EUR | 19 |
| 2022 | - | -15.3M | -17.1M | 56.7M | 20 |
| 2021 | - | -6.2M | -10.6M | 49.4M | 12 |
| 2020 | - | -1.1M | -3.5M | 640K | 8 |
| 2019 | - | -3M | -4.3M | 9.7M | 5 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Valcon Medical A/S has published its annual report for 2022. Gross profit came to DKK -15,349,994, and the net result was DKK -17,079,193.
As of June 29, 2023, E Stanton Mclean has joined the board of directors of Valcon Medical A/S.
As of June 27, 2023, Diego Francisco Gomez Dueñas has left the board of directors of Valcon Medical A/S.
About Valcon Medical A/S
Valcon Medical A/S is a Danish company of the type Aktieselskab based in Lynge, founded in 2018. The company is registered under the industry Fremstilling af andre organiske basiskemikalier. The company was previously named Aureum A/S. The management consists of Peter Emil Guldmann Sigetty. The board consists of Alex Sung Kwon (chair), Douglas Fischer, Ruchir Ashok Kadakia and William Muecke. The company is owned by BTS DK ApS. The company has 15 employees (2026). In 2025, the company reported a gross profit of DKK 2,139,839 and a net result of DKK -11,198,587 compared with EUR -41,728,331 the year before. Equity in the 2025 report amounted to DKK 11,420,803.
